Functional Outcomes and Mortality in Patients With Intracerebral Hemorrhage After Intensive Medical and Surgical Support
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objectives Despite decades of increasingly sophisticated neurocritical care, patient outcomes after spontaneous intracerebral hemorrhage (ICH) remain dismal. Whether this reflects therapeutic nihilism or the effects of the primary injury has been questioned. In this contemporary cohort, we determined the 30- and 90-day mortality, cause-specific mortality, functional outcome, and the effect of surgical intervention in a culture of aggressive medical and surgical support.
Methods This was a retrospective cohort study of consecutive adult patients with spontaneous ICH admitted to a tertiary neurocritical care unit. Patients with secondary ICH and those subject to limitation of care before 72 hours were excluded. For each ICH score, mortality at 30- and 90-days, and the modified Rankin Scale (mRS) within 1-year were examined. The effect of craniotomy/craniectomy ± hematoma evacuation on the outcome of supratentorial ICH was determined using propensity score matching. Median patient follow-up after discharge was 2.2 (interquartile range [IQR] 0.4–4.4) years.
Results Among 319 patients with spontaneous ICH (median age was 69 [IQR 60–77] years, 60% male), 30- and 90-day mortality were 16% and 22%, respectively, and unfavorable functional outcome (mRS score 4–6) was 50% at a median 3.1 months after ICH. Admission predictors of mortality mirrored those of the original ICH score. Unfavorable outcomes for ICH scores 3 and 4 were 73% and 86%, respectively. The most common adjudicated primary causes of mortality were direct effect or progression of ICH (54%), refractory cerebral edema (21%), and medical complications (11%). In matched analyses, lifesaving surgery for supratentorial ICH did not significantly alter mortality or unfavorable functional outcome in patients overall. In subgroup analyses restricted to (1) surgery with hematoma evacuation and (2) ICH score 3 and 4 patients, the odds of 30-day mortality were reduced by 71% (odds ratio [OR] 0.29, 95% CI 0.09–0.9, p = 0.032) and 80% (OR 0.2, 95% CI 0.04–0.91, p = 0.038), respectively, but no difference was observed for 90-day mortality or unfavorable functional outcome.
Discussion This study demonstrates that poor outcomes after ICH prevail despite aggressive treatment. Unfavorable outcomes appear related to direct effects of the primary injury and not to premature care limitations. Lifesaving surgery for supratentorial lesions delayed mortality but did not alter functional outcomes.
Glossary
- AUC=
- area under the curve;
- BP=
- blood pressure;
- CTA=
- CT angiography;
- ECL=
- early care limitation;
- ED=
- emergency department;
- GCS=
- Glasgow Coma Scale;
- ICH=
- intracerebral hemorrhage;
- ICU=
- intensive care unit;
- IQR=
- interquartile range;
- IVH=
- intraventricular hemorrhage;
- mRS=
- modified Rankin Scale;
- NCCU=
- neurocritical care unit;
- OR=
- odds ratio;
- ROC=
- receiver operating characteristic;
- SBP=
- systolic blood pressure;
- tPA=
- tissue plasminogen activator
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Editor-in-Chief José Merino, MD, MPhil, FAAN.
See page 891
- Received July 17, 2022.
- Accepted in final form January 17, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author Response: Functional Outcomes and Mortality in Patients With Intracerebral Hemorrhage After Intensive Medical and Surgical Support
- Yasser B. Abulhasan, MBChB, FRCPC, Staff Neurointensivist, Kuwait University
- Jeanne Teitelbaum, MD, FRCPC, Staff Neurointensivist, McGill University
- Khalsa Al-Ramadhani, MD, DABR-NR, Neuroradiologist, McGill University
- Kathryn T. Morrison, PhD, AStat, Statistician, McGill University
- Mark R. Angle, MD, Staff Neurointensivist, McGill University
Submitted May 10, 2023 - Reader Response: Functional outcomes and mortality in patients with intracerebral hemorrhage after intensive medical and surgical support
- Vishank A Shah, MD; Assistant Professor of Neurology, Staff Neurointensivist, Johns Hopkins University School of Medicine
- Lourdes Carhuapoma, MS, CRNP, CCRN, PhD; Neurocritical Care Nurse Practitioner, Johns Hopkins University School of Medicine
- Daniel F Hanley, MD; Professor of Neurology, Johns Hopkins University School of Medicine
- Wendy C Ziai, MD, MPH; Professor of Neurology, Staff Neurointensivist, Johns Hopkins University School of Medicine
Submitted April 14, 2023
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith